Pharmaceutical compounding (503B) is compounding pharmacies with outsourcing facilities that may manufacture large batches with or without prescriptions to be sold to healthcare facilities for office use only. 503B compounding pharmacies that provide patient-specific medications are held to higher regulatory standards. These facilities must comply with current good manufacturing practices (CGMP).
Community Discussions
Community Discussions
May 02, 2024
May 01, 2024
Apr 30, 2024
Apr 30, 2024
Apr 26, 2024
Apr 25, 2024
Data Integrity
GAMP
Apr 25, 2024